ANIX CIK: 715446

Anixa Biosciences Inc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.94
FY22:
−6.49
FY23:
−6.21
FY24:
−7.34
FY25:
−7.17
Change from FY21 to FY25
millions USD
FY21:
−3.92
FY22:
−10.7
FY23:
−5.60
FY24:
4.28
FY25:
4.87
Change from FY21 to FY25
millions USD
FY21:
31.6
FY22:
0.45
FY23:
0.37
FY24:
3.42
FY25:
2.28
millions USD
FY21:
22.7
FY22:
−16.8
FY23:
−11.4
FY24:
0.36
FY25:
−0.03

All amounts in millions USD Data source:SEC EDGAR